These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20101010)

  • 61. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.
    Esmatjes E; De Alvaro F;
    Diabetes Res Clin Pract; 2002 Jul; 57(1):35-43. PubMed ID: 12007728
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial.
    Philis-Tsimikas A; Fortmann A; Lleva-Ocana L; Walker C; Gallo LC
    Diabetes Care; 2011 Sep; 34(9):1926-31. PubMed ID: 21775748
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.
    Cook CB; Erdman DM; Ryan GJ; Greenlund KJ; Giles WH; Gallina DL; El-Kebbi IM; Ziemer DC; Ernst KL; Dunbar VG; Phillips LS
    Diabetes Care; 2000 Mar; 23(3):319-24. PubMed ID: 10868858
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension.
    Ohno T; Kato N; Shimizu M; Ishii C; Ito Y; Tomono S; Kawazu S; Murata K
    Diabetes Res; 1993; 22(3):115-21. PubMed ID: 8076444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Importance of measuring non-HDL cholesterol in type 2 diabetes patients.
    Ram N; Ahmed B; Hashmi F; Jabbar A
    J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
    George PB; Tobin KJ; Corpus RA; Devlin WH; O'Neill WW
    Am Heart J; 2001 Nov; 142(5):857-63. PubMed ID: 11685175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
    Lam KS; Cheng IK; Janus ED; Pang RW
    Diabetologia; 1995 May; 38(5):604-9. PubMed ID: 7489845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
    Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
    Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
    Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus.
    Rodríguez-Vigil E; Rodríguez-Chacón M; Trabanco C; Irizarry-Ramos J
    P R Health Sci J; 2014 Dec; 33(4):157-62. PubMed ID: 25563032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes.
    Bjornstad P; Pyle L; Nguyen N; Snell-Bergeon JK; Bishop FK; Wadwa RP; Maahs DM
    Pediatr Diabetes; 2015 Feb; 16(1):22-30. PubMed ID: 25604668
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?
    Nielsen LR; Damm P; Mathiesen ER
    Diabetes Care; 2009 Jan; 32(1):38-44. PubMed ID: 18945922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Positive health beliefs are associated with improvement of glycated hemoglobin and lipid profiles in Mexican patients with type 2 diabetes mellitus: a cross-sectional study.
    Muñoz-Torres AV; Medina-Bravo P; Valerio-Pérez BE; Mendoza-Salmeron G; Escobedo-de la Peña J; Velázquez-López L
    BMC Public Health; 2020 May; 20(1):761. PubMed ID: 32448139
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study.
    Yamada T; Komatsu M; Komiya I; Miyahara Y; Shima Y; Matsuzaki M; Ishikawa Y; Mita R; Fujiwara M; Furusato N; Nishi K; Aizawa T
    Diabetes Care; 2005 Nov; 28(11):2733-8. PubMed ID: 16249548
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
    Freedman BI; Wuerth JP; Cartwright K; Bain RP; Dippe S; Hershon K; Mooradian AD; Spinowitz BS
    Control Clin Trials; 1999 Oct; 20(5):493-510. PubMed ID: 10503809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.
    Ménard J; Payette H; Baillargeon JP; Maheux P; Lepage S; Tessier D; Ardilouze JL
    CMAJ; 2005 Dec; 173(12):1457-66. PubMed ID: 16293781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.